[go: up one dir, main page]

GR3023065T3 - Pressurised aerosol compositions - Google Patents

Pressurised aerosol compositions

Info

Publication number
GR3023065T3
GR3023065T3 GR970400733T GR970400733T GR3023065T3 GR 3023065 T3 GR3023065 T3 GR 3023065T3 GR 970400733 T GR970400733 T GR 970400733T GR 970400733 T GR970400733 T GR 970400733T GR 3023065 T3 GR3023065 T3 GR 3023065T3
Authority
GR
Greece
Prior art keywords
pressurised aerosol
surfactant
propellant
aerosol compositions
medicament
Prior art date
Application number
GR970400733T
Other languages
English (en)
Inventor
Asit Somani
Clive Booles
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909014527A external-priority patent/GB9014527D0/en
Priority claimed from GB909014526A external-priority patent/GB9014526D0/en
Priority claimed from GB909023953A external-priority patent/GB9023953D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of GR3023065T3 publication Critical patent/GR3023065T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Fertilizers (AREA)
GR970400733T 1990-06-29 1997-04-08 Pressurised aerosol compositions GR3023065T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909014527A GB9014527D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909014526A GB9014526D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909023953A GB9023953D0 (en) 1990-11-03 1990-11-03 Pharmaceutical composition
PCT/GB1991/001023 WO1992000061A1 (en) 1990-06-29 1991-06-25 Pressurised aerosol compositions

Publications (1)

Publication Number Publication Date
GR3023065T3 true GR3023065T3 (en) 1997-07-30

Family

ID=27265168

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400733T GR3023065T3 (en) 1990-06-29 1997-04-08 Pressurised aerosol compositions

Country Status (21)

Country Link
US (1) US5846521A (el)
EP (1) EP0536235B1 (el)
JP (1) JP2854974B2 (el)
AT (1) ATE147973T1 (el)
AU (1) AU8055691A (el)
BR (1) BR9106595A (el)
CA (1) CA2085884C (el)
CZ (1) CZ392592A3 (el)
DE (1) DE69124374T2 (el)
DK (1) DK0536235T3 (el)
ES (1) ES2096653T3 (el)
FI (1) FI925852A0 (el)
GR (1) GR3023065T3 (el)
HU (1) HUT63554A (el)
IE (1) IE912220A1 (el)
MX (1) MX9100008A (el)
NO (1) NO924954D0 (el)
NZ (1) NZ238746A (el)
PT (1) PT98133A (el)
SK (1) SK392592A3 (el)
WO (1) WO1992000061A1 (el)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
CZ271493A3 (en) * 1991-06-10 1994-07-13 Schering Corp Aerosol preparations without chlorofluorinated hydrocarbons
ZA924163B (en) * 1991-06-10 1993-02-24 Schering Corp Non-chlorofluorocarbon aerosol formulations
CA2421976C (en) 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
JPH08507792A (ja) * 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
JP3987963B2 (ja) * 1993-03-17 2007-10-10 スリーエム カンパニー エステルー，アミド−又はメルカプトエステル−誘導分散促進剤を含むエーロゾル配合物
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
DE69432224T2 (de) * 1993-12-02 2003-12-04 Abbott Laboratories, Abbott Park Aerosole als darreichungsform mit cfc-freiem treibmittel
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6461591B1 (en) 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6585958B1 (en) 1998-07-24 2003-07-01 Jago Research Ag Medicinal aerosol formulations
US6475467B1 (en) * 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
WO2002024623A2 (en) 2000-09-22 2002-03-28 Glaxo Group Limited Novel alkanoic acid derivatives
CA2433335C (en) 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
US7182961B2 (en) 2001-11-20 2007-02-27 Advanced Inhalation Research, Inc. Particulate compositions for pulmonary delivery
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
WO2003059317A2 (en) * 2001-12-21 2003-07-24 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
JP2005517701A (ja) 2002-02-13 2005-06-16 グラクソ　グループ　リミテッド 界面活性剤として使用するためのカルボン酸化合物
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US8198354B2 (en) 2003-08-11 2012-06-12 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
EP1658105B1 (en) 2003-08-29 2018-03-14 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
PT2425820E (pt) 2007-02-11 2015-08-04 Map Pharmaceuticals Inc Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
DE3872635T2 (de) * 1987-04-09 1992-12-17 Fisons Plc Pentamidin enthaltende pharmazeutische zusammensetzungen.
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8828544D0 (en) * 1988-12-07 1989-01-11 Ici Plc Chemical process
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments

Also Published As

Publication number Publication date
EP0536235A1 (en) 1993-04-14
HU9204098D0 (en) 1993-03-29
HUT63554A (en) 1993-09-28
NO924954L (no) 1992-12-21
JP2854974B2 (ja) 1999-02-10
IE912220A1 (en) 1992-01-01
ATE147973T1 (de) 1997-02-15
FI925852L (fi) 1992-12-23
FI925852A7 (fi) 1992-12-23
BR9106595A (pt) 1993-04-20
NO924954D0 (no) 1992-12-21
DK0536235T3 (da) 1997-04-14
US5846521A (en) 1998-12-08
EP0536235B1 (en) 1997-01-22
CA2085884A1 (en) 1991-12-30
PT98133A (pt) 1992-04-30
MX9100008A (es) 1992-02-03
NZ238746A (en) 1992-10-28
WO1992000061A1 (en) 1992-01-09
AU8055691A (en) 1992-01-23
ES2096653T3 (es) 1997-03-16
FI925852A0 (fi) 1992-12-23
SK392592A3 (en) 1994-07-06
CZ392592A3 (en) 1993-05-12
DE69124374D1 (de) 1997-03-06
CA2085884C (en) 2001-12-04
DE69124374T2 (de) 1997-06-19
JPH05507712A (ja) 1993-11-04

Similar Documents

Publication Publication Date Title
GR3023065T3 (en) Pressurised aerosol compositions
IL97065A0 (en) Aerosol propellant compositions
NZ333986A (en) Aerosol formulation comprising a medicament, a fluorocarbon propellant, 6-25% of a polar co-solvent and being substantially free of surfactant
AU1275395A (en) Novel foaming compositions, particularly for rectal foams, and resulting foams
YU48509B (sh) Suspenzije u kondenzovanim potisnim gasovima
CA2178473A1 (en) Flunisolide aerosol formulations
HK86593A (en) Pharmaceutical compositions containing cyclosporins
DE69223322D1 (de) Haarspraypraeparate
EP0366154A3 (en) Use of a composition as a cosmetic product
MXPA03006999A (es) Composicion limpiadora espumante suave.
EP0047122A3 (en) Intranasal formulation
EP0882761A3 (en) Azeotropic composition of 1,1,1,2-tetrafluoroethane and dimethyl ether
CA2062779A1 (en) Sterilizing gas composition comprising monochlorotetrafluorethane and ethylene oxide
PL328916A1 (en) Compositions containing inhibitors of hiv protease, such as vx 478 and water-soluble vitamin e compound such as vitamin e-tpgs
CA2176458A1 (en) Foaming Agent for Leave-On Foaming Cosmetic Compositions
JPS51116185A (en) An aerosol composition
MY107927A (en) Prewash cleaner compositions
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
MY108690A (en) Mildewproofing agent for timber
MX9707807A (es) Agente generador de espuma no ionico para composiciones cosmeticas espumosas.
ES2091008T3 (es) Agente para el cuidado del cabello.
MX9707238A (es) Formulaciones en aerosol de butixocort.
CA2141039A1 (en) Surfactant free aerosol formulations containing beclomethasone dipropionate
MX9704888A (es) Dispositivo para el almacenamiento separado de al menos dos productos, su mezcla y la distribucion de la mezcla obtenida de este modo y el procedimiento de fabricacion.
ES2163142T3 (es) Nuevos peptidos y agente neotropico.